Genomic Testing Cooperative

GTC now delivers preliminary DPYD results in just 5 days as part of our solid tumor testing, with comprehensive DNA + RNA profiling results available in 10 days or less—all from a single test.

One sample. One test. Actionable insights, delivered faster.

Learn more: https://genomictestingcooperative.com/genomic-tests/solid-tumor-profile-plus/

Rare tumors require deeper molecular insight.

In this case, GTC's comprehensive DNA + RNA profiling detected an SFPQ::TFE3 fusion, confirming a rare TFE3-rearranged vaginal PEComa that could have been misclassified as carcinoma or melanoma.

When morphology overlaps, RNA fusion testing can make the difference—enabling accurate diagnosis and more informed treatment decisions.

Read the case study:https://genomictestingcooperative.com/wp-content/uploads/Sarcoma-Case-Study-TFE3-Rearranged-Vaginal-v.3.0-05.26.pdf